Showing results (1441-1450 of 1,668) with videos related to

Sort By:
Pageof 167
Intensive Care Medicine|February 1, 2023
Epidemiology, clinical presentation, and outcomes of 620 patients with eosinophilia in the intensive care unitAntoine Gaillet, Pierre Bay, Edwige Péju, et al.
Cell|March 15, 2024
Rigorous science demands support of transgender scientistsKrisha Aghi, Brendan M Anderson, Bria M Castellano, et al.
Plos One|August 4, 2022
Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trialAlexandra Audemard-Verger, Amélie Le Gouge, Vincent Pestre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2017
Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled TrialXavier Puéchal, Christian Pagnoux, Gabriel Baron, et al.
Lancet (London, England)|June 29, 2020
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trialRaj R Makkar, Wen Cheng, Ron Waksman, et al.
Plos One|September 16, 2017
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patientsMikael Ebbo, Aurélie Grados, Maxime Samson, et al.
Immunometabolism|July 16, 2021
oxLDL-Induced Trained Immunity Is Dependent on Mitochondrial Metabolic ReprogrammingLaszlo A Groh, Anaisa V Ferreira, Leonie Helder, et al.
Scientific Reports|March 19, 2021
Venous thrombosis and predictors of relapse in eosinophil-related diseasesValériane Réau, Alexandre Vallée, Benjamin Terrier, et al.
Iscience|February 13, 2023
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variantsCamille Chauvin, Laurine Levillayer, Mathilde Roumier, et al.
Cell Reports|June 18, 2023
Dimethyl itaconate induces long-term innate immune responses and confers protection against infectionAnaísa V Ferreira, Sarantos Kostidis, Laszlo A Groh, et al.
Pageof 167